Login
Healthy outcome for M&A partners
Partners from Allens and Gilbert + Tobin have advised on a major acquisition in the healthcare sector.
Digital
Firms: Allens (Healthscope Limited); Gilbert + Tobin (Crescent Capital Partners)
To continue reading the rest of this article, please log in.
Create free account to get unlimited news articles and more!
Deal: Healthscope Limited’s sale of its Australian pathology operations to Crescent Capital Partners.
Value: $105 million
Area: M&A
Key players: The Allens team was led by partner-elect Emin Altiparmak (pictured), with support from partner and co-head of the firm’s private equity practice, Mark Malinas. The team also comprised partners and lawyers from the firm’s Melbourne, Sydney and Brisbane offices.
Gilbert + Tobin partners advised Crescent.
Deal significance: Healthscope’s Australian pathology operations consist of about 550 collection centres and 31 pathology laboratories in Victoria, South Australia, New South Wales and the Northern Territory.
The sale will also see Healthscope transfer six skin clinics to Crescent.
The deal was announced to the market on 23 June 2015 and is expected to be completed next month.
Mr Malinas said this deal was part of a continuing trend that has seen heavy private equity interest in the Australian healthcare sector.
“We have seen significant deals in this sector involving private equity, in particular in the area of retirement homes and hospitals. This deal indicates that private equity appetite for Australian healthcare assets is still there.”
